JLP:Jubilee Metals dropped 15% so glad I sold some last week.
CAML:Central Asia Metals dropped 9% and has lost 17% over 2 weeks to go to a 1% loss.
CEY:Centamin dropped 6% for no obvious reason, although the price of gold did dip a little.
SAE:Simec Atlantis Energy dropped 5% and maybe my decision to buy some more a few weeks ago was a really bad one.
SMS:Smart Metering Systems also dropped 5% for no reason
OPTI:Optibiotix fell another 2p in a relentless downward spiral, which after my purchase last week cost me £3,600 of the £5,000 loss.
No shares deserve Share of the Week yet again.
Still below the injection line
Looks like we've gone below the worst ever - Whoopee!
Here's the ISA and shares portfolio after week 41 of year 7.
| Weekly Change | |||
| Cash | £10.18 |
+£0 | |
| Portfolio cost | £82,912.77 | +£0 | |
| Portfolio sell value (bid price-commission) | £39,421.95 | (-52.5%) | -£2,290.98 |
| Potential profits | £1,325.55 | -£94.50 | |
| Yr 7 Dividends | £10,425.77 | +£0 | |
| Yr 7 Profit from sales | £3,970.12 | +£0 | |
| Yr 7 projected avg monthly profit | £1,518.35 | (41.2%) | -£37.95 |
| Total Dividends | £11,768.92 | +£0 | |
| Total Profit from sales | £28,094.06 | +£0 | |
| Average monthly cash profit |
£485.52 |
(13.2%) | -£1.38 |
|
(Sold stocks profit + Dividends - Fees / Months) |
|||
| Compound performance | 89% | +0% |
Not much to say other than everything down
Below injection line = bad
Worst ever
The SIPP looks like this after week 337 overall and week 25 of year 7.
As with the ISA there are lots of losses and nothing is in profit any more. My monthly investment went through, buying 68 shares of APAX:Apax Global Alpha at 186.687p costing £128.45.
Below injection line
Looks about equal with worst ever so holding up a bit better than the ISA
The trading account looks like this after week 303 overall and week 43 of year 6.
Disaster as DDDD:4D Pharma continues to be trashed
Not as bad as it has been
Time to celebrate - we're above the trend line!
| Weekly Change | ||||
| Cash | £112.99 | +£1.55 | ||
| Portfolio cost | £95,431.30 | +£128.44 | ||
|
Portfolio sell value (bid price - commission) |
£48,488.12 | (-49.2%) | -£2,677.10 | |
| Potential profits | £0 | -£84.64 | ||
| Yr 7 Dividends | £10,565.04 | +£0 | ||
| Yr 7 Interest | £0 | +£0 | ||
| Yr 7 Profit from sales | £358.14 | +£0 | ||
| Yr 7 projected avg monthly profit | £1,878.94 | (42.3%) | -£78.28 | |
| Total Dividends | £13,769.43 | +£0 | ||
| Total Interest | £0.20 | +£0 | ||
| Total Profit from sales | £24,082.77 | +£0 | ||
| Average monthly cash profit | £475.08 | (10.7%) | -£1.42 | |
|
(Sold stocks profit + Dividends - Fees / Months) |
||||
| Compound performance | 69% | -1% |
As with the ISA there are lots of losses and nothing is in profit any more. My monthly investment went through, buying 68 shares of APAX:Apax Global Alpha at 186.687p costing £128.45.
Below injection line
Looks about equal with worst ever so holding up a bit better than the ISA
The trading account looks like this after week 303 overall and week 43 of year 6.
| Weekly Change | |||
| Cash | £259.74 | +£0 | |
| Portfolio cost | £2,374.14 | +£0 | |
| Portfolio sell value (bid price - commission) | £729.83 | (-69.3%) | -£40.96 |
| Potential profits | £0.00 | +£0 | |
| Year 6 Dividends | £0.00 | +£0 | |
| Year 6 Profit | £0.00 | +£0 | |
| Yr 6 projected avg monthly profit | £0.00 | (0%) | +£0 |
| Dividends | £60.10 | +£0 | |
| Profit from sales | £937.88 | +£0 | |
| Average monthly cash profit | £14.27 | (7.2%) | -£0.05 |
|
(Sold stocks profit + Dividends - Fees / Months) |
Disaster as DDDD:4D Pharma continues to be trashed
Not as bad as it has been
Time to celebrate - we're above the trend line!
Utterly hopeless - I'm tempted to stop writing this until something nice
happens.
No comments:
Post a Comment